Next, to investigate the immune functions of MSI2 in CRC in vivo, transgenic mice with overexpression of Msi2 driven by the Villin promoter were generated and validated (Fig. 1D-E and Fig. S2A-B). Here, MSI2 is linked to colorectal carcinoma.